Terms ending in 2027
Every in-force patent on Ablynx N.V.'s record whose computed term ends in 2027, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,028,816 | Polypeptides and Polypeptide Constructs Comprising Single Domain Antibodies Directed Against Von Willebrand Factor In force · High confidence | Ablynx N.V. | In force | High confidence | |
| US 10,618,966 | Methods for the Treatment of INTERLEUKIN-6 Receptor-Related Diseases and Disorders In force · High confidence | Ablynx N.V. | In force | High confidence | |
| US 7,939,277 | Methods and Assays for Distinguishing Between Different Forms of Diseases and Disorders Characterized by Thrombocytopenia And/Or by Spontaneous Interaction Between Von Willebrand Factor (VWF) and Platelets In force · High confidence | Ablynx N.V. | In force | High confidence | |
| US 9,617,341 | Methods for Blocking or Reducing Binding of INTERLEUKIN-6 to INTERLEUKIN-6 Receptor In force · High confidence | Ablynx N.V. | In force | High confidence | |
| US 9,611,326 | INTERLEUKIN-6 Receptor Binding Polypeptides In force · High confidence | Ablynx N.V. | In force | High confidence | |
| US 9,605,072 | Nucleic Acids That Encode INTERLEUKIN-6 Receptor Binding Polypeptides In force · High confidence | Ablynx N.V. | In force | High confidence | |
| US 10,844,123 | Amino Acid Sequences That Modulate the Interaction Between Cells of the Immune System In force · High confidence | Ablynx N.V. | In force | High confidence | |
| US 9,512,236 | Amino Acid Sequences Directed Against Gpcrs and Polypeptides Comprising the Same for the Treatment of Gpcr-Related Diseases and Disorders In force · High confidence | Ablynx N.V. | In force | High confidence |
8 of 8 patents shown. Soonest term end first, then patent number.
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.